Monday, April 28, 2014
MolecularHealth Bolsters Scientific Advisory Board
The Woodlands, Texas-based MolecularHealth said today that it has bolstered its advisory board, adding three new members to the group. According to the company, which develops personalized medicine products, it has added Dr. Stephen Jones, most recently medical director of research for US Oncology Research; Thomas Kean, CEO and President of C-Change; and Kathleen Lokay, CEO of Via Oncology, all to its advisory board. The three will help as the company looks to launch a cancer treatment decision support product, the company said.